Depression, myocardial infarction and the immune system - The chicken before the egg problem

Harefuah

Volumn 143, Issue 1, 2004, Pages 73-78+83

  Rimar, Liat ^a   Rimar, Doron ^b  

^a Adult Probation Office   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acute myocardial infarction; Immune system; Inflammation; Ischemic heart disease; Major depression; Psychoimmunology

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN DERIVATIVE;

CARDIOVASCULAR RISK; CELL MEMBRANE; DEPRESSION; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INFLAMMATION; ISCHEMIC HEART DISEASE; LIPID COMPOSITION; MORBIDITY; MORTALITY; REVIEW; RISK FACTOR; THROMBOCYTE ACTIVATION; VASCULAR ENDOTHELIUM; ACUTE DISEASE; BLOOD; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SURVIVAL;

ACUTE DISEASE; DEPRESSION; DEPRESSIVE DISORDER; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INTERLEUKINS; MYOCARDIAL INFARCTION; RISK FACTORS; SURVIVAL;

EID: 1842534057     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Ziegelstein RC, Depression after myocardial infarction. Cardiol Rev, 2001; 9: 45-51.
2. Rugulies R, Depression as a predictor for coronary heart disease a review and meta-analysis. Am J Prev Med, 2002; 23: 51-61.
3. Frasure-Smith N, Lesperance F, Gravel G & al, Social support depression, and mortality during the first year after myocardia infarction. Circulation, 2000; 101: 1919-24.
4. Welin C, Lappas G & Wilhelmsen L, Independent importance of psychosocial factors for prognosis after myocardial infarction. J Intern Med, 2000; 247: 629-39.
5. Frasure-Smith N, Lesperance F & Talajic M, Depression and 18-month prognosis after myocardial infarction. Circulation, 1995; 91: 999-1005.
6. Strike PC & Steptoe A, Depression, stress, and the heart. Heart, 2002; 88: 441-3.
7. Penninx BW, Beekman AT, Honig A & al, Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry, 2001; 58: 221-7.
8. Ziegelstein RC, Depression in patients recovering from a myocardial infarction. JAMA, 2001; 286: 1621-7.
9. Strik JJ, Honig A & Maes M, Depression and myocardial infarction: relationship between heart and mind. Prog Neuropsychopharmacol Biol Psychiatry, 2001; 25: 879-92.
10. Dijkstra JB, Strik JJ, Lousberg R & al, Atypical cognitive profile in patients with depression after myocardial infarction. J Affect Disord, 2002; 70: 181-90.
11. Lane D, Carroll D, Ring C & al, Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med, 2001; 63: 221-30.
12. Lesperance F, Frasure-Smith N, Talajic M & al, Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation, 2002; 105: 1049-53.
13. Koenig W, Inflammation and coronary heart disease: an overview. Cardiol Rev, 2001; 9: 31-5.
14. Ritker PM, Rifai N, Rose L & al, Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med, 2002; 347: 1557-65.
15. Pannitteri G, Marino B, Campa PP & al, Interleukins 6 and 8 as mediators of acute phase response in acute myocardial infarction. Am J Cardiol, 1997; 80: 622-5.
16. Shibata M, Endo S, Inada K & al, Elevated plasma levels of interleukin-I receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res, 1997; 17: 145-50.
17. Gurfinkel E, Bozovich G, Beck E & al, Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study. Eur Heart J, 1999; 20: 121-7.
18. Appels A, Bar FW, Bar J & al, Inflammation, depressive symptomtology, and coronary artery disease. Psychosom Med, 2000; 62: 601-5.
19. Honig A & Maes M, Psychoimmunology as a common pathogenic pathway in myocardila infarction, depression and cardiac death. Curr Opin Psych, 2000; 13: 661-664.
20. Kop WJ, Gottdiener JS, Tangen CM & al, Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol, 2002; 89: 419-24.
21. Maes M, Scharpe S, Meltzer H & al, Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res, 1993; 49: 11-27.
22. Maes M, Bosmans E, Meltzer H & al, Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry, 1993; 150: 1189-93.
23. Maes M, Meltzer H, Bosmans E & al, Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord, 1995; 34: 301-9.
24. Maes M, Meltzer H, Buckley P & al, Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression. Eur Arch Psychiatry Clin Neurosci, 1995; 244: 325-9.
25. Meydani SN, Lichtenstein AH, Cornwall S & al, Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived N-3 fatty acid enrichment. J Clin Invest, 1993; 92: 105-13.
26. Maes M, Christophe A, Delanghe J & al, Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res, 1999; 85: 275-91.
27. Carney RM, Blumenthal JA, Stein PK & al, Depression, heart rate variability, and acute myocardial infarction. Circulation, 2001; 104: 2024-8.
28. Hosenpud JD, Campbell SM & Mendelson DJ, Interleukin-1-induced myocardial depression in an isolated beating heart preparation. J Heart Transplant, 1989; 8: 460-4.
29. Rajagopalan S, Broo R, Rubenfire M & al, Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. Am J Cardiol, 2001; 88: 196-8, A7.
30. Nemeroff CB & Musselman DL, Are platelets the link between depression and ischemic heart disease? Am Heart J, 2000; 140(4 Suppl): 57-62.
31. Delisi SM, Konopka LM, O'Connor FL & al, Platelet cytosolic calcium responses to serotonin in depressed patients and controls: relationship to symptomatology and medication. Biol Psychiatry, 1998; 43: 327-34.
32. Ziegelstein RC, Fauerbach JA, Stevens SS & al, Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med, 2000; 160: 1818-23.
33. Hamalainen H, Smith R, Puukka P & al, Social support and physical and psychological recovery one year after myocardial infarction or coronary artery bypass surgery. Scand J Public Health, 2000; 28: 62-70.
34. Ter Horst GJ, Emotions and heart disease. Harv Heart Lett, 1998; 8: 3-4.
35. Zalcman S, Green-Johnson JM, Murray L & al, Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res, 1994. 643: 40-9.
36. ENRICHD Investigators, Enhancing Recovery in Coronary Heart Disease (ENRICHD) study intervention: rationale and design. Psychosom Med, 2001; 63: 747-55.
37. Sheps DS, Freedland KE, Golden RN & al, ENRICHD and SADHART: implications for future biobehavioral intervention efforts. Psychosom Med, 2003; 65: 1-2.
38. Strik JJ, Honig A, Lousberg R & al, Clinical correlates of depression following myocardial infarction. Int J Psychiatry Med, 2001; 31: 255-64.
39. Glassman AH, O'Connor CM, Califf RM & al, Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA, 2002; 288: 701-9.
40. van den Brink RH, van Melle JP, Honig A & al, Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT). Am Heart J, 2002; 144: 219-25.